FIELD: medicine, pharmaceutics.
SUBSTANCE: there is offered an agent stimulating hemopoietic stem cells (HSCs) emission in blood flow; said method is characterised by the fact that it contains at least one phosphorylated polyisoprenoid presented with polyprenylphosphate or dolichil-phosphate with N isoprene links in number 7 to 22.
EFFECT: invention provides 6-14-fold increase of HSCs number in blood flow, and the agent works permanently without considerable changes in bone marrow and spleen for restoring action in bone marrow transplantation, in treatment of severe infectious diseases.
2 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL MEDICINE | 1991 |
|
RU2038083C1 |
5-OXYPYRIMIDINE DERIVATIVE POSSESSING ANTINEOPLASTIC ACTIVITY | 2011 |
|
RU2518889C2 |
MEDICATION FOR REDUCTION OF HEPATITIS C VIRUS REPRODUCTION | 2013 |
|
RU2526179C1 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
REMEDY FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME | 2022 |
|
RU2806867C1 |
METHOD FOR ACCELERATING POST-RADIATION RECOVERY OF SPLEEN IN LABORATORY ANIMALS | 2021 |
|
RU2774030C1 |
PEPTIDE HAVING EFFECT ON REGENERATION OF HOMOGENIC AND IMMUNE SYSTEMS, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 1996 |
|
RU2121480C1 |
IMMUNOMODULATOR METABOLITE DETOXICANT - ADAPTOGEN RADIOPROTECTOR | 2000 |
|
RU2194502C2 |
METHOD OF PROTECTING ANIMALS FROM HIGH-DOSE IONIZING RADIATION | 2019 |
|
RU2701155C1 |
Authors
Dates
2010-06-27—Published
2007-06-20—Filed